Alserawan, L., Anguera, G., Zamora, C., Serra, J., Martinez-Martinez, L., Riudavets Melià, M., . . . Vidal, S. (2022). Association between Changes in the Patterns of Antinuclear Autoantibodies during Immune Checkpoint Inhibition Therapy and the Development of Severe Immune Related Adverse Events.
Citación estilo ChicagoAlserawan, Leticia|||0000-0003-0428-9844, et al. Association between Changes in the Patterns of Antinuclear Autoantibodies During Immune Checkpoint Inhibition Therapy and the Development of Severe Immune Related Adverse Events. 2022.
Cita MLAAlserawan, Leticia|||0000-0003-0428-9844, et al. Association between Changes in the Patterns of Antinuclear Autoantibodies During Immune Checkpoint Inhibition Therapy and the Development of Severe Immune Related Adverse Events. 2022.